Causality assessment of cutaneous adverse drug reactions

Annals of Dermatology

Volumn 23, Issue 4, 2011, Pages 432-438

  Son, Young Min ^a   Lee, Jong Rok ^a   Roh, Joo Young ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Cutaneous adverse drug reactions; Korean algorithm; Naranjo algorithm

Indexed keywords

EID: 82555203058     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2011.23.4.432     Document Type: Article

References (28)

1. Shear NH, Knowles SR, Shapiro L. Cutaneous reactions to drugs. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's dermatology in general medicine. 7th ed. New York: McGraw-Hill, 2008: 355-362.
2. James WD, Berger TG, Elston DM. Andrews' disease of the skin. 10th ed. Philadelphia: WB Saunders, 2006:115-138.
3. Knowles SR, Shear NH. Cutaneous drug reactions with systemic features. In: Wolverton SE, editors. Comprehensive dermatologic drug therapy. 2nd ed. Indianapolis: Saunders Elsevier, 2007:977-988.
4. Revuz J, Valeyrie-Allanore. Drug reaction. In: Bolognia J, Jorizzo J, Rapini R, editors. Dermatology. 1st ed. Philadelphia: Mosby, 2003:333-353.
5. Kwon KS, Kim BS, Jang BS, Kim MB, Oh CK, Kwon YW, et al. Clinical study of drug rash with eosinophilia and systemic symptoms (DRESS) on drug eruption patients over the last 10 years (1995-2004). Korean J Dermatol 2005;43:1164-1169.
6. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-1285. (Pubitemid 24333193)
7. Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 2003;4:561-572. (Pubitemid 36995078)
8. Roujeau JC. Treatment of severe drug eruptions. J Dermatol 1999;26:718-722.
9. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995;155: 1949-1956.
10. Kim KJ, Jeong MC, Yoo JH. Clinical study and skin tests of patients with drug eruption. Korean J Dermatol 1998; 36:887-896.
11. Shin KS, Cho KH, Lee YS. Clinical study of hospitalized patients with drug eruption during a 10-year reriod (1975-1985). Korean J Dermatol 1987;25:176-182. (Pubitemid 18094479)
12. Kim SN, Lee BH. Clinical study for drug eruptions. Korean J Dermatol 1978;16:377-381.
13. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245. (Pubitemid 12149145)
14. Hong KS, Park BJ, Sin SG, Yang JS, Lee SM, Kim YN, et al. Development of a Korean algorithm for causality assessment of adverse drug reactions. Korean J Clin Pharmacol Ther 2002;10:129-142.
15. Franceschi M, Scarcelli C, Niro V, Seripa D, Pazienza AM, Pepe G, et al. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 2008; 31:545-556. (Pubitemid 351693687)
16. Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2007;2:79-87. (Pubitemid 46723172)
17. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-1205. (Pubitemid 28193431)
18. Bang DS, Cho CK, Lee SN. Statistical study of dermatoses during the last 5 years (1976?1980). Korean J Dermatol 1983;21:37-44.
19. Hahm JH. A comparative study on clinical evaluation of inpatient dermatology consultation between 1976 and 1991. Korean J Dermatol 1992;30:651-658.
20. Becquemont L. Pharmacogenomics of adverse drug reactions: practical applications and perspectives. Pharmacogenomics 2009;10:961-969.
21. Lee SM, Hahn SK, Park BJ. Signal detection and causality evaluation for pharmacovigilance. Korean J Clin Pharmacol Ther 2005;13:121-133
22. Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, et al. Adverse drug reaction monitoring: doing it the French way. Lancet 1985;2:1056-1058. (Pubitemid 16206749)
23. Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46: 1323-1330. (Pubitemid 23333873)
24. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991;266:2847-2851.
25. Dormann H, Muth-Selbach U, Krebs S, Criegee-Rieck M, Tegeder I, Schneider HT, et al. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf 2000;22:161-168. (Pubitemid 30072060)
26. Hogan DJ. Morbilliform drug eruptions. J Am Acad Dermatol 2009;61:152.
27. Gerson D, Sriganeshan V, Alexis JB. Cutaneous drug eruptions: a 5-year experience. J Am Acad Dermatol 2008; 59:995-999.
28. Gendernalik SB, Galeckas KJ. Fixed drug eruptions: a case report and review of the literature. Cutis 2009;84:215-219.